Novel metal complexes for targeted anticancer therapy
Introducing novel metal complexes with enhanced cytotoxicity and selectivity towards cancer cells, offering potential for new anticancer therapies with reduced side effects and improved efficacy.
Overview
The research focuses on the development of novel metal complexes designed to target cancer cells with increased cytotoxicity and selectivity compared to traditional chemotherapy drugs. These metal complexes can be tailored to interact with specific cellular processes, potentially overcoming the limitations of organic compounds and offering new mechanisms of action against cancer. Their ability to selectively target cancer cells minimizes damage to healthy cells, reducing side effects and improving patient outcomes.
Technical specifications
The metal complexes are engineered to interact uniquely with cancer cell biomarkers, offering selective internalization and retention in pancreatic ductal adenocarcinoma (PDAC) cells. They show potential in reversing multidrug resistance and can be used synergistically with existing anticancer agents to enhance treatment efficacy. The research involves:
- Identifying overexpressed biomarkers in PDAC
- Designing metal complexes for targeted uptake
- Utilizing imaging techniques for cellular visualization
- Conducting uptake assays and analyzing interaction kinetics
- Comparing efficacy with existing treatments
Technology readiness level
The development of these metal complexes is at TRL 4, indicating that the technology has been validated in a laboratory environment and is preparing for more extensive testing and validation, including preclinical and clinical studies.
About University of Georgia
The University of Georgia is a comprehensive public land‑grant research university serving a large student body across multiple campuses, known for applied scholarship and community partnership. Industry partners access core facilities and pilot‑scale capabilities—including the Food Product Innovation and Commercialization Center—for prototyping, scale‑up, and product validation. A downtown Innovation District and a statewide Cooperative Extension network link campus expertise to companies across Georgia, while proximity to Atlanta’s corporate and logistics hubs lowers barriers to engagement. Research is supported by competitive federal funding from agencies such as NIH, NSF, USDA, and DOE. A dedicated technology transfer office provides IP services, licensing, startup support, and incubator space to accelerate commercialization.
Inquire about this partnering listing
Industry applications
delivered to your inbox.